These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20381386)

  • 1. Embolic protection devices: no room for standardization.
    Setacci C
    Eur J Vasc Endovasc Surg; 2010 Jun; 39(6):667. PubMed ID: 20381386
    [No Abstract]   [Full Text] [Related]  

  • 2. The CABARNET trial more evidence...but what's next?
    Moussa ID
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):961-2. PubMed ID: 18500701
    [No Abstract]   [Full Text] [Related]  

  • 3. Techniques in cerebral protection.
    Fanelli F; Bezzi M; Boatta E; Passariello R
    Eur J Radiol; 2006 Oct; 60(1):26-36. PubMed ID: 16872779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on "embolization during carotid angioplasty and stenting: what is the optimal method for detecting embolic debris and its sequelae?".
    Bassiouny H
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):270-1. PubMed ID: 18930935
    [No Abstract]   [Full Text] [Related]  

  • 5. Embolic protection devices for carotid artery stenting: have they made a significant difference in outcomes?
    Atkins MD; Bush RL
    Semin Vasc Surg; 2007 Dec; 20(4):244-51. PubMed ID: 18082841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on "the impact of embolic protection device and stent design on the outcome of CAS".
    Wholey MH
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):280-1. PubMed ID: 18930937
    [No Abstract]   [Full Text] [Related]  

  • 7. Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABERNET trial.
    Hopkins LN; Myla S; Grube E; Wehman JC; Levy EI; Bersin RM; Joye JD; Allocco DJ; Kelley L; Baim DS
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):950-60. PubMed ID: 18412236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size and nature of emboli produced during carotid artery angioplasty and stenting: in vivo study.
    Brightwell RE; Ryder TA; Hamady M; Cheshire NJ
    Int J Surg; 2011; 9(2):177-82. PubMed ID: 21081185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid stenting with a new system for distal embolic protection and stenting in high-risk patients: the carotid revascularization with ev3 arterial technology evolution (CREATE) feasibility trial.
    Safian RD; Bacharach JM; Ansel GM; Criado FJ
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):1-6. PubMed ID: 15343559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of embolic protection device and stent design on the outcome of CAS.
    Bosiers M; Deloose K; Verbist J; Peeters P
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):272-9. PubMed ID: 18930936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow reversal for cerebral protection in carotid artery stenting: a review.
    Kelso R; Clair DG
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):282-90. PubMed ID: 18930938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embolic protection devices: methods, techniques, and data.
    Yadav JS
    Tech Vasc Interv Radiol; 2004 Dec; 7(4):190-3. PubMed ID: 16084443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries.
    Quan VH; Huynh R; Seifert PA; Kuchela A; Chen WH; Sütsch G; Eisenhauer AC; Rogers C
    Am J Cardiol; 2005 Jun; 95(12):1415-9. PubMed ID: 15950562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis.
    Ballotta E
    Circulation; 2001 Nov; 104(22):E121-2. PubMed ID: 11723035
    [No Abstract]   [Full Text] [Related]  

  • 15. Carotid artery stenting: an update.
    Spiliopoulos S; Vasiniotis Kamarinos N; Reppas L; Palialexis K; Brountzos E
    Curr Opin Cardiol; 2019 Nov; 34(6):616-620. PubMed ID: 31436557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embolization during carotid angioplasty and stenting : what is the optimal method for detecting embolic debris and its sequelae?
    DeRubertis BG
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):260-9. PubMed ID: 18930934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does carotid stent design influence outcomes?
    Bersin RM
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):863-6. PubMed ID: 19006255
    [No Abstract]   [Full Text] [Related]  

  • 18. Carotid stenting with and without protection devices: should protection be used in all patients?
    Ohki T; Veith FJ
    Semin Vasc Surg; 2000 Jun; 13(2):144-52. PubMed ID: 10879555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting.
    Gray WA; Yadav JS; Verta P; Scicli A; Fairman R; Wholey M; Hopkins LN; Atkinson R; Raabe R; Barnwell S; Green R;
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):1025-33. PubMed ID: 18044758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 10 most commonly asked questions about carotid artery stent placement.
    Taylor RA; Qureshi AI
    Neurologist; 2007 Sep; 13(5):318-22. PubMed ID: 17848872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.